Skip to main content

Table 1 Demographic data of all patients

From: The clinical and radiological effectiveness of autologous bone marrow derived osteoblasts (ABMDO) in the management of avascular necrosis of femoral head (ANFH) in sickle cell disease (SCD)

Age (Years)

25.93 ± 5.48

Females

41

Males

22

Ficat I

5

Ficat II

47

Ficat III

11

Follow Up (Months)

40.05 ± 8.9 (range 24–48)